These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9256424)

  • 1. Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity.
    Wagner PD; Steeg PS; Vu ND
    Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9000-5. PubMed ID: 9256424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histidine to aspartate phosphotransferase activity of nm23 proteins: phosphorylation of aldolase C on Asp-319.
    Wagner PD; Vu ND
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):623-30. PubMed ID: 10698688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-directed mutation of Nm23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro.
    Freije JM; Blay P; MacDonald NJ; Manrow RE; Steeg PS
    J Biol Chem; 1997 Feb; 272(9):5525-32. PubMed ID: 9038158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double mutant P96S/S120G of Nm23-H1 abrogates its NDPK activity and motility-suppressive ability.
    Zhou Q; Yang X; Zhu D; Ma L; Zhu W; Sun Z; Yang Q
    Biochem Biophys Res Commun; 2007 May; 356(2):348-53. PubMed ID: 17335772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point mutations affecting the oligomeric structure of Nm23-H1 abrogates its inhibitory activity on colonization and invasion of prostate cancer cells.
    Kim YI; Park S; Jeoung DI; Lee H
    Biochem Biophys Res Commun; 2003 Jul; 307(2):281-9. PubMed ID: 12859952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
    Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
    Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells.
    MacDonald NJ; Freije JM; Stracke ML; Manrow RE; Steeg PS
    J Biol Chem; 1996 Oct; 271(41):25107-16. PubMed ID: 8810265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway.
    Hartsough MT; Morrison DK; Salerno M; Palmieri D; Ouatas T; Mair M; Patrick J; Steeg PS
    J Biol Chem; 2002 Aug; 277(35):32389-99. PubMed ID: 12105213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of geranyl and farnesyl pyrophosphates by Nm23 proteins/nucleoside diphosphate kinases.
    Wagner PD; Vu ND
    J Biol Chem; 2000 Nov; 275(45):35570-6. PubMed ID: 10952986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells.
    Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM
    Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.
    Hartsough MT; Clare SE; Mair M; Elkahloun AG; Sgroi D; Osborne CK; Clark G; Steeg PS
    Cancer Res; 2001 Mar; 61(5):2320-7. PubMed ID: 11280805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory activity of nm23-H1 on invasion and colonization of human prostate carcinoma cells is not mediated by its NDP kinase activity.
    Lee HY; Lee H
    Cancer Lett; 1999 Oct; 145(1-2):93-9. PubMed ID: 10530775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel serine/threonine-specific protein phosphotransferase activity of Nm23/nucleoside-diphosphate kinase.
    Engel M; VĂ©ron M; Theisinger B; Lacombe ML; Seib T; Dooley S; Welter C
    Eur J Biochem; 1995 Nov; 234(1):200-7. PubMed ID: 8529641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 is a regulator of the metastasis suppressor gene Nm23-H1.
    Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH
    Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wild-type NM23-H1, but not its S120 mutants, suppresses desensitization of muscarinic potassium current.
    Otero AS; Doyle MB; Hartsough MT; Steeg PS
    Biochim Biophys Acta; 1999 Mar; 1449(2):157-68. PubMed ID: 10082974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of nm23 H1/nucleoside diphosphate kinase A mRNA associated with adenocarcinoma of the prostate.
    Jensen SL; Wood DP; Banks ER; Veron M; Lascu I; McRoberts JW; Rangnekar VM
    World J Urol; 1996; 14 Suppl 1():S21-5. PubMed ID: 8738406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential.
    MacDonald NJ; De la Rosa A; Benedict MA; Freije JM; Krutsch H; Steeg PS
    J Biol Chem; 1993 Dec; 268(34):25780-9. PubMed ID: 8245015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression.
    Khan MH; Yasuda M; Higashino F; Haque S; Kohgo T; Nakamura M; Shindoh M
    Am J Pathol; 2001 May; 158(5):1785-91. PubMed ID: 11337376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleoside diphosphate kinase A/nm23-H1 promotes metastasis of NB69-derived human neuroblastoma.
    Almgren MA; Henriksson KC; Fujimoto J; Chang CL
    Mol Cancer Res; 2004 Jul; 2(7):387-94. PubMed ID: 15280446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of the nm23.h1 gene inhibits cell proliferation.
    Cipollini G; Berti A; Fiore L; Rainaldi G; Basolo F; Merlo G; Bevilacqua G; Caligo MA
    Int J Cancer; 1997 Oct; 73(2):297-302. PubMed ID: 9335458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.